ClinicalTrials.gg
Sign In

BiologicalDrug

Nilvanstomig clinical trials

Also written ZG005.

studies test it
15
open now
12
in phase 3
2
first study started
2022

Keep track of what changes. Save the nilvanstomig studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

ZG005 for Injection
7
ZG005 Powder for Injection
3

Development codes

ZG005
14

Studies by the year they started

15 studies that test it; most in 2025 (8)

Studies that test nilvanstomig, by start year
YearStudies
20221
20244
20258
20262

By phase

A phase 1/2 study counts in both.

Phase 1
10
Phase 2
13
Phase 3
2

What it is tested for

Each study’s main condition, where its own words name it.

Carcinoma, Neuroendocrine
2
Carcinoma, Hepatocellular
2
Carcinoma, Non-Small-Cell Lung
1
Lymphoma
1
Small Cell Lung Carcinoma
1
Uterine Cervical Neoplasms
1
Carcinoma
1

Who runs them

Industry 15 · Other 0

Suzhou Zelgen Biopharmaceuticals Co.,Ltd (15)

Often tested with

Tested in the same studies.

Jaktinib (4) · Bevacizumab (2) · Cisplatin (2) · Tislelizumab (1) · Anti-VEGF/TGF-beta Bispecific Antibody Fusion Protein ZGGS18 (1) · Alveltamig (1) · Sintilimab (1) · Etoposide (1)

Studies

Open first, then newest update. How each study uses nilvanstomig is read from its arms, and is right about nine times in ten.

Testing it · 15

Given in every arm · 1 — nilvanstomig is usual care beside what is tested

Codes

What other systems call nilvanstomig · ClinicalTrials.gg INT014504

  • UNII (FDA) 2NQG7P8ET6NILVANSTOMIGOne source FDA
  • NCI Thesaurus C208073NilvanstomigOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.